Kezar Life Sciences
KZR | NASDAQ
$7.29
$0.00 (0.00%)
At close: May 8, 2026, 4:00 PM ET
+0.00%
(1D)Rating
Key Statistics
Market Data
Market Cap $53.86M
1D Range
7.29 7.29
52W Range
3.53 7.55
Valuation (TTM)
PE -1.18
PB 0.83
EV/EBITDA 0.35
Valuation (NTM)
Forward PE N/A
Forward PEG 0.04
Price Target $11.00
Cash Flow
FCF Yield -78.0%
SBC Adj. FCF Yield -90.7%
SBC Impact -16.3%
Margins
Gross Margin 0.0%
Operating Margin 0.0%
FCF Margin N/A
Growth (CAGR)
Revenue 3Y | 5Y -150.0% |
0.0%
Dil EPS 3Y | 5Y -54.3% |
-48.8%
FCF 3Y | 5Y 33.0% |
1.8%
Returns
ROA -66.5%
ROE -58.4%
ROIC -63.1%
Financial Health
Net Cash
$64.88M
Current Ratio 24.46
Interest Coverage -50.01
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Kezar Life Sciences, Inc. is a United States-based clinical-stage biopharmaceutical company focused on identifying and advancing novel small molecule therapies. Its mission is to address significant u...
Sector Healthcare
Industry Biotechnology
Employees 55
IPO Date Jun 21, 2018
Website auriniapharma.com
Fiscal Year January - December
Latest News
No news articles available yet.
Analyst Summary
# of Analysts
3
Consensus
Hold
Price Target
$7.00
Downside
-3.98%
Buy (0)
Hold (2)
Sell (0)
Add to Watchlist
Select watchlists to add or remove KZR